Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Operating Margin (2019 - 2025)

Bioadaptives' Operating Margin history spans 7 years, with the latest figure at 2379.56% for Q4 2025.

  • Quarterly results put Operating Margin at 2379.56% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 5701.79% (down 94932.0% YoY), and the annual figure for FY2025 was 5701.79%, down 94932.0%.
  • Operating Margin for Q4 2025 was 2379.56% at Bioadaptives, up from 5735.95% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 415.47% in Q1 2024 to a low of 13774.52% in Q2 2024.
  • The 5-year median for Operating Margin is 2392.01% (2023), against an average of 3447.4%.
  • The sharpest move saw Operating Margin tumbled -1138251bps in 2024, then skyrocketed 510043bps in 2025.
  • Year by year, Operating Margin stood at 4615.27% in 2021, then soared by 85bps to 685.29% in 2022, then decreased by -25bps to 857.99% in 2023, then tumbled by -1505bps to 13774.52% in 2024, then skyrocketed by 83bps to 2379.56% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 2379.56%, 5735.95%, and 8674.09% for Q4 2025, Q3 2025, and Q2 2025 respectively.